Dr Hannah Keage
http://www.eclipsestudy.eu (personal home page)
I am involved in the harmonisation and anslysis of three existing European longitudinal clinicpathological datasets of ageing for the project ‘European Clinicopathologial Studies in Europe’ or EClipSE. It is hoped that results from the EClipSE study will improve our understanding of the biological substrates and psychological factors involved in the clinical manifestation of dementia. Please visit our study wesite - www.eclipsestudy.eu.
I am currently funded by a Marie Curie International Incoming Research Fellowship.
EClipSE Collaborative Members, Brayne C, Ince PG, Keage HA, McKeith IG, Matthews FE, Polvikoski T, Sulkava R (2010), “Education, the brain and dementia: neuroprotection or compensation?” Brain 133(Pt 8):2210-6 Details
Eclipse Collaborative Members (2009), “Cohort profile: Epidemiological Clinicopathological Studies in Europe (EClipSE).” J Alzheimers Dis Details
Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, Wharton SB, Weller RO, Brayne C (2009), “Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.” BMC Neurol 9(1):3 Details
Keage HA, Matthews FE, Yip A, Gao L, McCracken C, McKeith IG, Rubinsztein DC, Brayne C, MRC Cognitive Function and Ageing Study (2009), “APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.” Age Ageing Details
Sawyer AC, Clark CR, Keage HA, Moores KA, Clarke S, Kohn MR, Gordon E (2009), “Cognitive and electroencephalographic disturbances in children with attention-deficit/hyperactivity disorder and sleep problems: New insights.” Psychiatry Res Details
Alexander DM, Hermens DF, Keage HA, Clark CR, Williams LM, Kohn MR, Clarke SD, Lamb C, Gordon E (2008), “Event-related wave activity in the EEG provides new marker of ADHD.” Clin Neurophysiol 119(1):163-79 Details
Keage HA, Clark CR, Hermens DF, Williams LM, Kohn MR, Clarke S, Lamb C, Crewther D, Gordon E (2008), “ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication.” J Clin Neurophysiol 25(1):32-41 Details
Keage HAD, Clark, C.R.., Hermens DF, Clark S, Kohn M, Williams L, Crewther D, Lamb C, & Gordon E (2008), “ Putative biomarker of working memory systems development over childhood and adolescence” NeuroReport 19(2):197-201
Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, Clark CR, Gordon E (2008), “Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.” Biol Psychiatry 63(10):917-26 Details
Keage HA, Clark CR, Hermens DF, Kohn MR, Clarke S, Williams LM, Crewther D, Lamb C, Gordon E (2006), “Distractibility in AD/HD predominantly inattentive and combined subtypes: the P3a ERP component, heart rate and performance.” J Integr Neurosci 5(1):139-58 Details
Cooper NJ, Keage H, Hermens D, Williams LM, Debrota D, Clark CR, Gordon E (2005), “The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.” J Integr Neurosci 4(1):123-44 Details
Tlauka, M., Keage, H., & Clark, CR. (2005), “Viewing a map versus reading a description of a map: modality-specific encoding of spatial information. ” Cognitive Science 29 (5), 807-818.